Predicting outcomes of dual antihypertensive therapy

Author:

Okorokova T. O.1ORCID,Krjuchkova O. N.2ORCID

Affiliation:

1. N.I. Pirogov Kerch hospital №1

2. V.I. Vernadsky Crimean Federal University

Abstract

Objective:to establish predictors of failure of dual antihypertensive therapy in patients with arterial hypertension (AH) of high and very high cardiovascular risk, to create a predicting model for the negative outcome of dual antihypertensive therapy. Materials and methods: The study included 88 patients with uncontrolled hypertension who did not receive basic antihypertensive therapy, mean age 58.0±1.52 years. The examination was carried out on the basis of the current regulatory documents regulating the examination at the stationary stage. Additionally, the level of highly sensitive C-reactive protein and blood uric acid was determined. 24-hour blood pressure monitoring (ABPM) and electrocardiogram (ECG), respiratory polygraphy of sleep, and computerized  capillaroscopy  were performed. The search for predictors and the creation of a predictive model were carried out using  the binary logistic  regression method. Results: the effectiveness of dual drug therapy was 33.0%. Prognostic markers associated with a negative outcome of treatment were identified: interventricular septal thickness (IVS) (OR 3.44; p=0.009), linear density of the capillary network (OR 4.65, p<0.001), area density of the capillary network (OR 3, 98; p<0.001); remodeling  coefficient (OR 8.40; p=0.003), mean nighttime systolic blood pressure (SBP) (OR 1.94; p=0.014), mean daily SBP (OR 2.86; p=0.014), SDNNi (OR 2 .86; p=0.007). The final model included the IVS, areal density of the capillary network, and the average daily SBP. Model characteristics: regression coefficient 25.74; p<0.001; p Wald 0.049; OR 9.1 (95% CI 3.12; 26.82). The sensitivity of the method was 83.1%, the specificity was 69.0%. The area under the ROC curve was 0.805±0.05 (95% CI 0.707; 0.882). The cut-off point corresponded to the calculated probability value of 0.599. Conclusions: the study demonstrated the low efficacy of dual antihypertensive therapy. Given the lack of approved algorithms for predicting outcomes of drug treatment in patients with uncontrolled hypertension, the developed model is of clinical interest and may be useful in achieving better BP control. To improve the quality of the model in order to increase the sensitivity and specificity of the method, further study on larger samples is required.

Publisher

Rostov State Medical University

Subject

General Medicine

Reference16 articles.

1. Kobalava Zh.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., Arutyunov G.P., Baranova E.I. i dr. Arterial'naya gipertenziya u vzroslykh. Klinicheskie rekomendatsii 2020. Rossiiskii kardiologicheskii zhurnal. 2020;25(3):3786. DOI: 10.15829/1560-4071-2020-3-3786.

2. Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Journal of Hypertension. 2018;36(10):1953-2041. DOI: 10.1097/HJH.0000000000001940

3. Ikeda N., Sapienza D., Guerrero R., Aekplakorn W., Naghavi M., Mokdad A.H. et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ. 2014;92(1):10-9. DOI: 10.2471/BLT.13.121954

4. Böhm M., Schumacher H., Teo K.K., Lonn E.M., Mahfoud F.,Mann J.F.E.et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389(10085): 2226-2237. DOI: 10.1016/S0140-6736(17)30754-7

5. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA.2002;288(5):2981-2997. DOI: 10.1001/jama.288.23.2981

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3